Autolus Therapeutics (AUTL) Interest & Investment Income (2017 - 2026)
Autolus Therapeutics' Interest & Investment Income was $1.88 million in Q2 2026, down 64.1% from $5.23 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Interest & Investment Income (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Autolus Therapeutics' Interest & Investment Income was $14.72 million through Jun 30, 2026, down 45.8% year-over-year; for FY2025, it came in at $18.98 million, down 41.3% from FY2024.
- Interest & Investment Income shows a five-year compound annual growth rate of 104.1% (FY2020 to FY2025).
- In earlier years, Interest & Investment Income was $32.36 million in FY2024 (+139.6%), $13.51 million in FY2023 (+690.7%), $1.71 million in FY2022 (+551.9%) and $262,000 in FY2021 (-51.1%).
- The Q2 2026 figure marks the lowest quarterly Interest & Investment Income since Q4 2022.
- Compared with a year earlier, Interest & Investment Income was higher in two of the last seven quarters, with growth averaging 7.2%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q4 2022 (growth of 857.0%); the worst was Q2 2026 (a decline of 64.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Autolus Therapeutics | 631.98 Mn | -692.11 Mn | 25.22 Mn | 1.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Dec 31, 2024 | 7.45 Mn |
| Sep 30, 2024 | 8.32 Mn |
| Jun 30, 2024 | 9.66 Mn |
| Mar 31, 2024 | 6.93 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 89,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 149,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 42,000.00 |
API Access
Autolus Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();